openPR Logo
Press release

Asthma Market SWOT Analysis by Key Players: 2A Pharma AB, 3SBio, 4D Pharma

11-16-2020 04:19 PM CET | Health & Medicine

Press release from: HTF Market Intelligence Consulting Pvt. Ltd.

Asthma Market

Asthma Market

A new research document is added in HTF MI database of 811 pages, titled as 'Asthma - Pipeline Review, H2 2020' with detailed analysis, Competitive landscape, forecast and strategies. Latest analysis highlights high growth emerging players and leaders by market share that are currently attracting exceptional attention. The identification of hot and emerging players is completed by profiling 50+ Industry players; some of the profiled players are 2A Pharma AB, 3SBio Inc, 4D Pharma Plc, AB Science SA, AbbVie Inc, Abeome Corp, Adamis Pharmaceuticals Corp, Adare Pharma Solutions, Advagene Biopharma Co Ltd, Aerami Therapeutics, Airbase Breathing Co LLC, Akeso Inc, Aldeyra Therapeutics Inc, Algomedix Inc, ALK-Abello AS, Allergan Ltd, AllerGen NCE Inc, Allergy Therapeutics Plc, Amgen Inc, Amphastar Pharmaceuticals Inc, AnGes Inc, Antisense Therapeutics Ltd, Apollo Therapeutics LLC, Aquilon Pharmaceuticals SA, ArcticZymes Technologies ASA, Argenx SE, Artax Biopharma Inc etc. The Market has witnessed continuous growth in the past few years and is projected to see some stability post Q2,2020 and may grow further during forecast year 2021-2026

Access sample report @ https://www.htfmarketreport.com/sample-report/2944635-asthma-pipeline-review-1

Summary
Asthma is a chronic disease involving the airways in the lungs. These airways, or bronchial tubes, allow air to come in and out of the lungs. Symptoms include shortness of breath, chest tightness or pain, chronic coughing and trouble sleeping due to coughing or wheezing. The predisposing factors include family history, overweight, smoking, exposure to exhaust fumes or other types of pollution and exposure to occupational triggers, such as chemicals used in farming, hairdressing and manufacturing. Treatment includes inhaled corticosteroids, leukotriene modifiers, antihistamines and decongestants.

Companies Mentioned in the Report
2A Pharma AB, 3SBio Inc, 4D Pharma Plc, AB Science SA, AbbVie Inc, Abeome Corp, Adamis Pharmaceuticals Corp, Adare Pharma Solutions, Advagene Biopharma Co Ltd, Aerami Therapeutics, Airbase Breathing Co LLC, Akeso Inc, Aldeyra Therapeutics Inc, Algomedix Inc, ALK-Abello AS, Allergan Ltd, AllerGen NCE Inc, Allergy Therapeutics Plc, Amgen Inc, Amphastar Pharmaceuticals Inc, AnGes Inc, Antisense Therapeutics Ltd, Apollo Therapeutics LLC, Aquilon Pharmaceuticals SA, ArcticZymes Technologies ASA, Argenx SE, Artax Biopharma Inc, Artizan Biosciences Inc, ASIT Biotech SA, Aslan Pharmaceuticals Ltd, AstraZeneca Plc, Cumberland Pharmaceuticals Inc, Cynata Therapeutics Ltd, Cytokinetics Inc, Daewoong Pharmaceutical Co Ltd, Daiichi Sankyo Co Ltd, Defensin Therapeutics ApS, Dnarx LLC, EffectorBio Inc, Eleusis Ltd, EmphyCorp Inc, Energenesis Biomedical Co Ltd, Enzychem Lifesciences Corp, ethris GmbH, EURRUS Biotech GmbH, Evelo Biosciences Inc, Exotect LLC, F. Hoffmann-La Roche Ltd, Fibrotherapeutics Inc, Foresee Pharmaceuticals Co Ltd, GeneFrontier Corp, Genentech USA Inc, Jiangsu Hengrui Medicine Co Ltd, JiangSu Qyuns Therapeutics Co Ltd, JW Pharmaceutical Corp, Kashiv BioSciences LLC, KBP BioSciences Co Ltd, Kissei Pharmaceutical Co Ltd, Kither Biotech Srl, KLUS Pharma Inc, Knopp Biosciences LLC, KoBioLabs Inc, Korea United Pharm Inc, Kyowa Kirin Co Ltd, Laboratorios LETI SLU, Landos Biopharma Inc, Laurel Therapeutics, Lead Discovery Center GmbH, Lignamed LLC, Liminal BioSciences Inc, Longevity Biotech Inc, Mabpharm Ltd, Mabtech Ltd, Mabwell Shanghai Bioscience Co Ltd, Mariposa Health Ltd, MD Healthcare Inc, Medicenna Therapeutics Corp, Mercia Pharma Inc, Merck & Co Inc, MitoImmune Therapeutics Inc, Translational Biosciences, Trio Medicines Ltd, Tunitas Therapeutics Inc, United Biomedical Inc, United BioPharma Inc, Vactech Oy, Vanworld Pharmaceutical (Rugao) Company Ltd, Vascular BioSciences, Vasomune Inc, Vectura Group Plc, Verona Pharma Plc, Vicenna Pharmaceuticals Inc, Yuhan Corp, Zhejiang Hisun Pharmaceutical Co Ltd

View Detailed Table of Content @ https://www.htfmarketreport.com/reports/2944635-asthma-pipeline-review-1

Report Highlights
Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Asthma - Pipeline Review, H2 2020, provides comprehensive information on the therapeutics under development for Asthma (Respiratory), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Asthma (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Asthma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 7, 16, 42, 36, 4, 126, 31 and 10 respectively. Similarly, the Universities portfolio in Phase II, Preclinical and Discovery stages comprises 1, 30 and 9 molecules, respectively.

Asthma (Respiratory) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Asthma (Respiratory).
- The pipeline guide reviews pipeline therapeutics for Asthma (Respiratory) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Asthma (Respiratory) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Asthma (Respiratory) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Asthma (Respiratory)

Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Asthma (Respiratory).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Asthma (Respiratory) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Get Customization in the Report, Enquire Now @ https://www.htfmarketreport.com/enquiry-before-buy/2944635-asthma-pipeline-review-1

Table of Contents
Introduction
Asthma - Overview
Asthma - Therapeutics Development
Asthma - Therapeutics Assessment
Asthma - Companies Involved in Therapeutics Development
Asthma - Drug Profiles
Asthma - Dormant Projects
Asthma - Discontinued Products
Asthma - Product Development Milestones
AppendixList of Tables
Number of Products under Development for Asthma, H2 2020
Number of Products under Development by Companies, H2 2020
Num

....Continued

Purchase Single User License of this report at USD2000@ https://www.htfmarketreport.com/buy-now?format=1&report=2944635

It's vital you keep your market knowledge up to date. If you have a different set of players/manufacturers according to geography or needs regional or country segmented reports we can provide customization accordingly.

Contact US :
Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
sales@htfmarketreport.com

About Author:
HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asthma Market SWOT Analysis by Key Players: 2A Pharma AB, 3SBio, 4D Pharma here

News-ID: 2188279 • Views:

More Releases from HTF Market Intelligence Consulting Pvt. Ltd.

Blockchain Technology in Energy Market to Witness Huge Growth by 2030: WePower, PowerChain, EnergyFintech
Blockchain Technology in Energy Market to Witness Huge Growth by 2030: WePower, …
The latest survey on Blockchain Technology in Energy Market is conducted to provide hidden gems performance analysis of Blockchain Technology in Energy to better demonstrate competitive environment. The study is a mix of quantitative market stats and qualitative analytical information to uncover market size revenue breakdown by key business segments and end-use applications. The report bridges the historical data from 2019 to 2023 and forecasted till 2030. The outbreak of
Disposable E-Cigarettes Market SWOT Analysis by Key Players- NJOY, YouMe, JAC Vapour
Disposable E-Cigarettes Market SWOT Analysis by Key Players- NJOY, YouMe, JAC Va …
The latest survey on Disposable E-Cigarettes Market is conducted to provide hidden gems performance analysis of Disposable E-Cigarettes to better demonstrate competitive environment. The study is a mix of quantitative market stats and qualitative analytical information to uncover market size revenue breakdown by key business segments and end-use applications. The report bridges the historical data from 2019 to 2023 and forecasted till 2030. The outbreak of the latest scenario in
North America Luxury Tourism Market Comprehensive Study Explores Huge Growth in Future: TUI Group, Oetker Collection, Accor
North America Luxury Tourism Market Comprehensive Study Explores Huge Growth in …
The latest study released on the North America Luxury Tourism Market by HTF MI Research evaluates market size, trend, and forecast to 2030. The North America Luxury Tourism market study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about
Automotive LiDAR Market May See a Big Move: Major Giants Velodyne Lidar, Ouster, Waymo, Aptiv
Automotive LiDAR Market May See a Big Move: Major Giants Velodyne Lidar, Ouster, …
The Automotive LiDAR Market has witnessed continuous growth in the past few years and is projected to grow at a good pace during the forecast period of 2024-2030. The exploration provides a 360° view and insights, highlighting major outcomes of Automotive LiDAR industry. These insights help business decision-makers to formulate better business plans and make informed decisions to improve profitability. Additionally, the study helps venture or emerging players in understanding

All 5 Releases


More Releases for Asthma

Asthma Treatment Market: Increase in Prevalence of Asthma and Rise in Awareness …
Transparency Market Research (TMR) has published a new report on the asthma treatment market for the forecast period of 2019–2027. According to the report, the global asthma treatment market was valued at ~US$ 25 Bn in 2018, and is projected to expand at a CAGR of ~2% from 2019 to 2027. Read Report Overview - https://www.transparencymarketresearch.com/asthma-treatment-market.html Overview Asthma treatment involves two main types of medications: long-term asthma control medications and quick-relief (rescue) medications. Asthma
Anti-Asthma Drugs Market Factors Affecting Market Growth 2018 | Key Type of Asth …
To Track and Analyze Competitive Developments such as Joint Ventures, Strategic Alliances, Mergers and Acquisitions, New Product Developments, and Research and Developments Globally. The all things added in “Global Anti Asthma Drugs Market Research Report – Forecast to 2022” – Avail Prime Report to MRFR Anti-Asthma Drugs Market - Overview With the air pollution rising around the world, the number of asthma patients is also increasing. Therefore the market for the drugs
Asthma-Pipeline Review H2 2017
ReportsWeb.com published “Asthma” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Asthma-Pipeline Review, H2 2017, provides an overview of the Asthma (Respiratory) pipeline landscape. Asthma is a chronic disease involving the airways in the lungs. These airways, or bronchial tubes, allow
Landmark Asthma Study Demonstrates Device Choice Determines Asthma Control
Monaghan Medical Corporation understands that for those with asthma, particularly children, choosing the device that best delivers their medication is an important consideration. Plattsburgh, NY, USA -- Monaghan Medical Corporation understands that for those with asthma, particularly children, choosing the device that best delivers their medication is an important consideration. Research has shown that even when using the same metered-dose inhaler (MDI), not all valved holding chambers perform equally well.[1] A landmark
Asthma-Pipeline Review H2 2017
ReportsWeb.com published “Asthma” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Asthma-Pipeline Review, H2 2017, provides an overview of the Asthma (Respiratory) pipeline landscape. Asthma is a chronic disease involving the airways in the lungs. These airways, or bronchial tubes, allow
Asthma Therapeutics Market to 2020 - Personalized Treatment for Severe Asthma to …
Recent Research, a leading business intelligence provider, has released its latest research report: “Asthma Therapeutics Market to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations.” The asthma therapeutics market is forecast to grow marginally over the forecast period across the top eight developed nations, from $18.4 billion in 2013 to a projected value of $21.7 billion by 2020 at a Compound Annual Growth Rate (CAGR)